Obesity, which can lead to a variety of chronic diseases and reduced life span, continues to increase in prevalence in the US. A subset of obese subjects (30 percent of those entering medical weight-loss programs) has the recently characterized binge-eating disorder (BED), ingestion of very large meals without purging as occurs in bulimia nervosa. We have shown that stomach capacity is greater in obese than lean subjects, but this may be due mainly to the BED subset. We hypothesize that stomach capacity is larger in obese BED subjects than in obese non-BED subjects and lean subjects. Stomach capacity will be estimated by filling a gastric balloon in 24 obese BED and 24 non-obese subjects and 24 lean controls, each group divided equally by sex. Gastric capacity will be estimated from a) maximum volume tolerated and b) volume required to induce a given rise in intragastric pressure. Gastric capacity will be correlated with laboratory test-meal intake. Gastric emptying of a liquid meal will also be determined and related to gastric capacity. From out previous work, we would predict slower emptying, especially in the early phase, from a stomach with a large capacity. During the gastric emptying test, blood will be sampled for plasma cholecystokinin (CCK), a satiety peptide, shown to be lower in bulimics postprandially. The reduced CCK in bulimics may be the result of slower gastric emptying and larger gastric capacity and is predicted to be reduced in BED. The extent to which gastric capacity and emptying, test meal intake, and CCK change after restrictive dieting in obese subjects will then be determined. The obese BED and non-BED subjects will be randomized for 3 mo. of a) cognitive-behavior modification with a recommended intake of 5016 kJ/day (1200 kcal/day) or b) ad-lib intake. Gastric capacity may not decline in BED subjects if it is a primary factor in the disorder. Body composition, including underwater weighing wil be assessed before and after this period. Afterwards, a double-blind, dose-response study of a gastric emptying accelerant (cisapride) will be conducted in 12 non-dieting subjects of each group. Especially for the BED group, cisapride may speed emptying, enhance CCK release, and increase satiety. The lowest effective dose will then be used in a double-blind, 2 month crossover clinical trial of 12 obese non-BED subjects. Body weight and composition will be assessed at the start and monthly. The studies may enhance knowledge of the etiology, pathophysiology, and treatment of BED.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK054318-03
Application #
6381198
Study Section
Special Emphasis Panel (ZRG1-IFCN-1 (01))
Program Officer
Yanovski, Susan Z
Project Start
1999-09-01
Project End
2005-08-31
Budget Start
2001-09-01
Budget End
2005-08-31
Support Year
3
Fiscal Year
2001
Total Cost
$275,007
Indirect Cost
Name
St. Luke's-Roosevelt Institute for Health Sciences
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10019
Gluck, Marci E; Yahav, Eric; Hashim, Sami A et al. (2014) Ghrelin levels after a cold pressor stress test in obese women with binge eating disorder. Psychosom Med 76:74-9
Geliebter, Allan (2013) Neuroimaging of gastric distension and gastric bypass surgery. Appetite 71:459-65
Geliebter, A; Carnell, S; Gluck, M E (2013) Cortisol and ghrelin concentrations following a cold pressor stress test in overweight individuals with and without night eating. Int J Obes (Lond) 37:1104-8
Tomasi, Dardo; Wang, Gene-Jack; Wang, Ruiliang et al. (2009) Association of body mass and brain activation during gastric distention: implications for obesity. PLoS One 4:e6847
Geliebter, Allan; Gluck, Marci E; Hashim, Sami A (2005) Plasma ghrelin concentrations are lower in binge-eating disorder. J Nutr 135:1326-30
Gluck, Marci E; Geliebter, Allan; Lorence, Margarita (2004) Cortisol stress response is positively correlated with central obesity in obese women with binge eating disorder (BED) before and after cognitive-behavioral treatment. Ann N Y Acad Sci 1032:202-7
Gluck, Marci E; Geliebter, Allan; Hung, Jennifer et al. (2004) Cortisol, hunger, and desire to binge eat following a cold stress test in obese women with binge eating disorder. Psychosom Med 66:876-81
Geliebter, Allan; Yahav, Eric K; Gluck, Marci E et al. (2004) Gastric capacity, test meal intake, and appetitive hormones in binge eating disorder. Physiol Behav 81:735-40
Sorbara, Maria; Geliebter, Allan (2002) Body image disturbance in obese outpatients before and after weight loss in relation to race, gender, binge eating, and age of onset of obesity. Int J Eat Disord 31:416-23
Gluck, M E; Geliebter, A; Satov, T (2001) Night eating syndrome is associated with depression, low self-esteem, reduced daytime hunger, and less weight loss in obese outpatients. Obes Res 9:264-7

Showing the most recent 10 out of 12 publications